UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
BioLife Solutions
BLFS
$1.69B
| $831K | ﹤0.01% |
38,184
+3,041
| +9% | +$68.4K |
|
2027
Varex Imaging
VREX
$778M
| $830K | ﹤0.01% |
45,603
+3,922
| +9% | +$74.6K |
|
|
AMWD
2028
DELISTED
American Woodmark
AMWD
| $828K | ﹤0.01% |
+15,909
| New | +$861K |
|
2029
Grid Dynamics Holdings
GDYN
$623M
| $827K | ﹤0.01% |
72,149
| – | – |
|
|
OLO
2030
DELISTED
Olo Inc
OLO
| $826K | ﹤0.01% |
101,166
-4,662
| -4% | -$35.9K |
|
2031
RPC Inc
RES
$1.36B
| $820K | ﹤0.01% |
106,652
+26,936
| +34% | +$239K |
|
|
DENN
2032
DELISTED
Denny's
DENN
| $819K | ﹤0.01% |
73,420
-774
| -1% | -$9K |
|
2033
RadNet
RDNT
$6.06B
| $814K | ﹤0.01% |
32,504
-3,177
| -9% | -$69.1K |
|
|
LPRO
2034
DELISTED
Open Lending Corp
LPRO
| $812K | ﹤0.01% |
115,368
| – | – |
|
|
ECHO
2035
EchoStar
ECHO
$25.7B
| $811K | ﹤0.01% |
44,346
-22,297
| -33% | -$408K |
|
2036
QuinStreet
QNST
$1.25B
| $809K | ﹤0.01% |
51,002
-3,860
| -7% | -$61K |
|
|
PFC
2037
DELISTED
Premier Financial Corp. Common Stock
PFC
| $808K | ﹤0.01% |
38,988
+3,075
| +9% | +$75.1K |
|
2038
Origin Bancorp
OBK
$1.63B
| $806K | ﹤0.01% |
25,082
| – | – |
|
2039
MGP Ingredients
MGPI
$377M
| $805K | ﹤0.01% |
+8,326
| New | +$814K |
|
2040
John B. Sanfilippo & Son
JBSS
$967M
| $804K | ﹤0.01% |
8,292
| – | – |
|
2041
National Beverage
FIZZ
$2.94B
| $803K | ﹤0.01% |
15,233
| – | – |
|
2042
Immunovant
IMVT
$8.14B
| $802K | ﹤0.01% |
51,722
+7,968
| +18% | +$138K |
|
2043
Navitas Semiconductor
NVTS
$3.48B
| $800K | ﹤0.01% |
109,475
+7,443
| +7% | +$41.7K |
|
2044
Braze
BRZE
$3.18B
| $796K | ﹤0.01% |
23,013
+1,431
| +7% | +$44.6K |
|
|
CHS
2045
DELISTED
Chicos FAS, Inc.
CHS
| $793K | ﹤0.01% |
144,153
-6,653
| -4% | -$35.5K |
|
|
FRG
2046
DELISTED
Franchise Group, Inc.
FRG
| $791K | ﹤0.01% |
29,037
+2,843
| +11% | +$81.8K |
|
2047
Sturm, Ruger & Co
RGR
$594M
| $790K | ﹤0.01% |
13,752
| – | – |
|
|
VGR
2048
DELISTED
Vector Group Ltd.
VGR
| $789K | ﹤0.01% |
65,692
-3,394
| -5% | -$42.8K |
|
|
DSEY
2049
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $787K | ﹤0.01% |
97,290
-2,454,287
| -96% | -$15.6M |
|
2050
Planet Labs
PL
$8.38B
| $784K | ﹤0.01% |
199,580
+61,090
| +44% | +$274K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.